Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis - Wikidata - wikimedia - TriplyDB

Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis

Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q35685088

about

A balancing act: efflux/influx in mycobacterial drug resistance New Antituberculosis Drugs: From Clinical Trial to Programmatic Use A structural basis for the antibiotic resistance conferred by an A1408G mutation in 16S rRNA and for the antiprotozoal activity of aminoglycosides Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa.Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and Streptomycin.Extensively drug-resistant tuberculosis: new strains, new challenges.Treatment of tuberculosis in children.High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment.Mycobacterium marinum infection in Drosophila melanogaster for antimycobacterial activity assessment.Drug Resistance Mechanisms in Mycobacterium tuberculosis.Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections.Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.In vitro drug susceptibility of Mycobacterium tuberculosis for amikacin, kanamycin and capreomycin.Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.PknE, a serine/threonine protein kinase from Mycobacterium tuberculosis has a role in adaptive responses.Exploring the Contribution of Mycobacteria Characteristics in Their Interaction with Human Macrophages

P2860

Q24644870-A72EEDCF-32FD-4864-A44C-FAA572BD0D5C Q26741138-D961253D-2150-4756-AAE5-6BF401946095 Q27675767-C380F8DC-CAAF-4CFB-9C3A-46D070943CD1 Q28481845-737DF8F4-55C5-455C-B869-811E23368D1A Q28485912-09CB5F43-8BCB-4BEF-9414-124BE8AC45F6 Q28487186-6A4EACC8-AE32-434C-8DDA-96608B1F4774 Q28487970-67FD4DE8-E449-44ED-AAAD-B138D218F922 Q33826477-0AC509F3-79A7-47CB-A374-E89AFC5F340E Q33827163-2D8C76F6-8CB6-452A-9E9A-21AA8F196AA0 Q33938148-E82C81B8-320D-4112-A902-5CAED60759F7 Q34169216-AB2C7FFD-903D-4F4A-B3A6-3CBBBF68EEF0 Q34922710-80776C37-76B6-4C1B-B896-C07CC6856B13 Q35943005-EA00FAD8-59F4-4438-BDA0-667C1EA8D001 Q37014494-B4F7921D-7638-4708-AA58-E746576197A6 Q37291363-F8BB246E-A6F6-4504-B65A-C83E2D9874B0 Q37340569-DB2C7691-668D-4E1B-866D-89C8D7CF567A Q37450730-6A936CA1-BF15-4E38-AB40-B8CE45CFA159 Q37612943-5DED218D-392B-4AD9-A7CC-ED2F8C721447 Q38044744-C1A66960-D329-44C6-9180-1EF9E7446A78 Q38456839-B93626F4-AA17-4903-9370-AF2D08183457 Q38792870-B0630DAC-F474-40D9-AB8D-5D7460BD5018 Q39030684-7CDA2828-BC9B-4F42-8DC1-2EAA6A227C3B Q40343208-EE164E60-EC99-4B2F-AACD-BC957A5C2CA8 Q46604521-A0486B1F-54CE-4992-A97E-6E05E3776393 Q50134142-BAB97447-C96C-47B5-90EE-41888F0EC985 Q50788130-D3120F5C-1B06-4455-81CF-23FA822241B7 Q51718512-5F516596-3FD5-4AE7-A047-E1582684EC8D Q52707803-47781E7C-9998-4D52-BD80-B7EEBD9D501C Q54474473-02084C50-6F04-4F95-89C6-EACC039BD234 Q57657211-7AE0A098-BE84-46E0-AE3C-09F3ECDF3AA2

P2860

Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q35685088

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Discordant resistance to kanam ...... ant Mycobacterium tuberculosis

@ast

Discordant resistance to kanam ...... ant Mycobacterium tuberculosis

@en

type

label

Discordant resistance to kanam ...... ant Mycobacterium tuberculosis

@ast

Discordant resistance to kanam ...... ant Mycobacterium tuberculosis

@en

prefLabel

Discordant resistance to kanam ...... ant Mycobacterium tuberculosis

@ast

Discordant resistance to kanam ...... ant Mycobacterium tuberculosis

@en

P1433

Q35685088-7CF5A6A4-F4FE-4B45-969C-4A6B0D3934AD

P1476

Q35685088-07AF0B12-2560-4FAD-BF41-C26E2B20DDB9

P2093

Q35685088-14ACC237-735C-4534-A125-6CD07B732836

Q35685088-66A34AAC-6BBE-424C-BE2A-0244C838FFD2

Q35685088-997C862A-655D-47DA-B1BC-664FC4A50C3D

Q35685088-B47AB919-59D6-46F8-A3F4-A40E728D4131

Q35685088-B7E10A67-4592-4F58-9867-974E568089A5

P2860

Q35685088-1CE3E0A7-92EA-4900-AA27-8C23B8FAE527

Q35685088-3B514961-194D-4624-8013-FAFB3FC09DC8

Q35685088-414E2AAA-AB16-41A9-9D21-69576DAC93F4

Q35685088-451BFF89-7777-4D21-B370-E3081DD19BFC

Q35685088-55C68994-AF2A-4D7F-8472-26BA58778F3E

Q35685088-6DA99690-14D5-4D76-85AC-71D13B5C4423

Q35685088-74A05C9A-3D99-418F-9F46-EAA1F3A0D88A

Q35685088-8AB5DF25-EB91-4755-BF53-D65771D15B30

Q35685088-9905E8B7-1B4C-48B9-8D5A-CDF971EC8CAE

Q35685088-9DB983CB-CBB3-43EA-A27D-48E6A12DBF93

P304

Q35685088-BB1FEEF5-480F-4C9F-B42E-FDCD566AD83C

P31

Q35685088-7233FE50-2257-4C01-81D5-74D4657908C6

P356

Q35685088-222ED07C-4A60-443A-BCEB-5C7CA078DC6B

P407

Q35685088-185D02F4-DBF8-4075-BFDB-D6BF5E4D8414

P433

Q35685088-A73BD670-4467-4D93-B11E-FB706F31F856

P478

Q35685088-DE979B31-A31C-4315-929A-E7A65A595457

P577

Q35685088-D99A5E05-D3CF-451A-BE46-4E069F48BB81

P5875

Q35685088-1BF73485-CFE4-460F-9070-F49F7354A491

P698

Q35685088-4FA15BA0-A4B0-4052-ACBE-947A11BCE4EC

P921

Q35685088-98EA2469-C7AA-462E-A1AF-18D308EE2D48

P932

Q35685088-5F52C3E5-A4D1-4BE1-AAFA-2FDB25D7EBBB

P356

AAC.47.9.2971-2973.2003

P1433

Antimicrobial Agents and Chemotherapy

P1476

Discordant resistance to kanam ...... ant Mycobacterium tuberculosis

@en

P2093

Annika Krüüner

http://www.w3.org/2001/XMLSchema#string

Klavdia Levina

http://www.w3.org/2001/XMLSchema#string

Pontus Jureen

http://www.w3.org/2001/XMLSchema#string

Solomon Ghebremichael

http://www.w3.org/2001/XMLSchema#string

Sven Hoffner

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

Interaction of antibiotics with functional sites in 16S ribosomal RNA

Molecular determinants of drug resistance in tuberculosis.

Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene.

Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis.

Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.

Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.

P304

2971-2973

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.47.9.2971-2973.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10599149

http://www.w3.org/2001/XMLSchema#string

P698

12937004

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

182599

http://www.w3.org/2001/XMLSchema#string